0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Brief Communications |

Normalization of Hyperhomocysteinemia with L-thyroxine in Hypothyroidism

Wiam I. Hussein, MD; Ralph Green, MD; Donald W. Jacobsen, PhD; and Charles Faiman, MD
[+] Article and Author Information

From The Cleveland Clinic Foundation, Cleveland, Ohio, and the University of California, Davis, Davis, California.


Presented in part at the Seventh Annual Meeting of the American Association of Clinical Endocrinologists, Orlando, Florida, April 1998, and the Second International Conference on Homocysteine Metabolism, Nijmegen, the Netherlands, April 1998.

Acknowledgments: The authors thank S.S. Reddy, MD, for recruiting patients and for support for the study; Jacob Selhub, PhD, Tufts University, for kindly doing the vitamin B6 assays; and Jeff Hammel for statistical analysis and advice.

Grant Support: By a research grant (Research Program Council #5669) from The Cleveland Clinic Foundation and grant HL52234 from the National Institutes of Health (Dr. Jacobsen).

Requests for Reprints: Charles Faiman, MD, Department of Endocrinology, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Desk A30, Cleveland, OH 44195; e-mail, faimanc1@cesmtp.ccf.org.

Current Author Addresses: Dr. Hussein: Saad Medical Center, PO Box 1991, Alkhobar, 31952, Saudi Arabia.

Dr. Green: Department of Pathology, University of California, Davis, Medical Center, 4400 V Street, Sacramento, CA 95817.

Dr. Jacobsen: Department of Cell Biology, Lerner Research Institute, The Cleveland Clinic Foundation, 9500 Euclid Avenue, NC10, Cleveland, OH 44195.

Dr. Faiman: Department of Endocrinology, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Desk A30, Cleveland, OH 44195.


Ann Intern Med. 1999;131(5):348-351. doi:10.7326/0003-4819-131-5-199909070-00005
Text Size: A A A

Background: Hyperhomocysteinemia is an independent risk factor for coronary, peripheral, and cerebrovascular disease. Elevated plasma homocysteine levels were described in a preliminary report on primary hypothyroidism.

Objective: To determine whether restoration of euthyroidism by L-thyroxine replacement therapy would reduce or normalize plasma homocysteine levels.

Design: Prospective cohort study.

Setting: Outpatient endocrinology department of a tertiary center.

Patients: 14 patients (10 women and 4 men; 25 to 77 years of age): 4 with newly diagnosed chronic (Hashimoto) hypothyroidism and 10 who had been rendered acutely hypothyroid (thyroid-stimulating hormone level > 25 mU/L) by total thyroidectomy for thyroid carcinoma.

Measurements: Total plasma homocysteine levels were measured at baseline and 3 to 9 months later, after euthyroidism had been attained by L-thyroxine replacement therapy.

Results: Median baseline plasma homocysteine levels in both sexes (women, 11.65 µmol/L [range, 7.2 to 26.5 µmol/L]; men, 15.1 µmol/L [range, 14.1 to 16.3 µmol/L]) were higher (P = 0.002) than those in healthy female (n = 35) and male (n = 36) volunteers (women, 7.52 µmol/L [range, 4.3 to 14.0 µmol/L]; men, 8.72 µmol/L [range, 5.94 to 14.98 µmol/L]). Eight patients (57%) had baseline plasma homocysteine levels that exceeded the upper limit of sex-specific reference ranges. Upon attainment of euthyroidism, all patients had a diminution in plasma homocysteine levels. The median overall change of −5.5 µmol/L (range, −15.4 to −1.8 µmol/L) corresponds to a difference of −44% (range, −58% to −13%) (P < 0.001). Homocysteine levels returned to normal in 7 of the 8 patients with elevated pretreatment values.

Conclusions: Hypothyroidism may be a treatable cause of hyperhomocysteinemia, and elevated plasma homocysteine levels may be an independent risk factor for the accelerated atherosclerosis seen in primary hypothyroidism.

Figures

Grahic Jump Location
Figure 1.
Vitamin interactions in the remethylation and the transsulfuration pathways of homocysteine metabolism.12CH 3 THFMS6CBS3

Vitamin B and folic acid, as 5-methyltetrahydrofolate ( ), are required for methionine synthase ( )-dependent remethylation of homocysteine. Vitamin B is required for cystathionine β-synthase ( ) activity and the conversion of cystathionine to cysteine in the transsulfuration pathway. DMG = dimethylglycine; S = substrate; SAH = S-adenosylhomocysteine; SAM = S-adenosylmethionine; SCH = methylated substrate; THF = tetrahydrofolate.

Grahic Jump Location
Grahic Jump Location
Figure 2.
Total plasma homocysteine levels by thyroid status and sex before and after normalization of thyroid-stimulating hormone levels byl-thyroxine replacement therapy.P

Dashed lines indicate the reference ranges (mean ± 2 SDs). The overall decline in median total plasma homocysteine levels was statistically significant ( < 0.001).

Grahic Jump Location

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Journal Club
Related Point of Care
Topic Collections
PubMed Articles

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)